Cell damage caused by personal lubricants does not increase HIV risk

November 7, 2012, Microbicide Trials Network

The use of certain water-based, over-the-counter personal lubricants can dry out and irritate vaginal and rectal tissue, but does not appear to increase susceptibility to HIV, according to a laboratory study published today in PLoS ONE. Even so, say study authors affiliated with the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), more research is needed to fully understand the safety of personal lubricants and their effect on epithelial tissue, the layer of mucosal cells that acts as the body's first line of defense against sexually transmitted HIV.

"We tested several kinds of personal and those that did the most damage to cell tissue were hyperosmolar," said lead study author Charlene S. Dezzutti, Ph.D., associate professor of obstetrics, gynecology and at the University of Pittsburgh School of Medicine and principal investigator of the MTN Network Laboratory.

"While we know there is cellular toxicity associated with hyperosmolar lubes, the damage did not appear to make cells more vulnerable to ," Dr. Dezzutti explained.

Hyperosmolar lubricants contain more salts, carbohydrates and proteins than are typically found inside cells of the vagina or rectum. This imbalance causes epithelial cells to lose water and, as a result, dry out. They are different from iso-osmolar lubricants, which contain the same amount of salts and other ingredients as do the cells.

Study investigators tested 14 brand-name over-the-counter and mail-order water-, lipid- and silicon-based lubricants. Lubricants selected were identified as those most commonly used during anal sex in a survey of more than 6,300 respondents. Results indicated that hyperosmolar water-based lubricants caused the most damage to the epithelium in the vagina and rectum compared to iso-osmolar water- and silicon-based lubricants. When the researchers applied the lubricants to vaginal tissue and then exposed it to HIV, they found that the lubricants did not increase susceptibility to HIV. Other studies are seeking to address HIV susceptibility with rectal tissue.

Of the lubricants tested, Good Clean Love and PRÉ, both water-based iso-osmolar lubricants, were shown to be least harmful to epithelial tissue, along with two silicon-based lubricants, Female Condom 2 and Wet Platinum. Lubricants that were most toxic to the (Gynol II, KY Jelly and Replens) also tended to damage "good" bacteria called lactobacillus, which is needed to maintain a healthy genital tract.

"Much more work needs to be done to explore the safety of lubes," said Dr. Dezzutti. "This was an early study and the jury is still out as to whether hyperosmolar lubes cause damage to the that in conjunction with other processes, like inflammation, could increase susceptibility to HIV."

"The most important point for people to take away from this study is that condoms are still the best way to protect against HIV and that lubes should always be used with compatible condoms."

Explore further: Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

Related Stories

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

May 17, 2012
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.